Pipeline Watch: 16 Japanese Approvals And Nine Phase III Trial Readouts
Executive Summary
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
You may also be interested in...
Galderma Hopes To Break Into Prurigo Nodularis Market, But May Face Rivals
The dermatology specialist announced positive results from the OLYMPIA 2 trial of nemolizumab, but Sanofi and Regeneron are already pursuing a similar indication for Dupixent.
Pipeline Watch: Nine Approvals And Phase III Trial Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Sirnaomics, SIGA Technologies and More
Recent executive changes in the industry include C-suite changes at Sirnaomics and Horizon Therapeutics. Meanwhile, new directors were appointed at SIGA Technologies and Forte Biosciences.